Christopher J. Recklitis, PhD, MPH, of Dana-Farber Cancer Institute, discusses a study investigating the availability of supportive care sexual aids and resources for cancer survivors at U.S. cancer centers (Abstract 134).
Flora E. van Leeuwen, PhD, of the Netherlands Cancer Institute, discusses cardiovascular disease risk after treatment-induced primary ovarian insufficiency in female survivors of Hodgkin lymphoma (Abstract 114).
Christopher J. Recklitis, PhD, MPH, of Dana-Farber Cancer Institute, summarizes two key papers on mental health: suicide risk among survivors of head and neck cancer vs other types of cancer; and the fear of cancer recurrence—its associations with mental health status and individual characteristics among cancer survivors (Abstract 146).
Genevieve Chaput, MD, of McGill University Health Centre, discusses an accredited workshop that increased primary care providers’ confidence and knowledge about cancer survivorship, which is key to supporting their growing role in post-treatment care (Abstract 20).
Patricia A. Ganz, MD, of the University of California, Los Angeles, and this year’s recipient of the Ellen Stovall Award for Advancement of Cancer Survivorship Care, discusses her 30-year-long career researching and advocating for survivors and quality care.
Lawrence N. Shulman, MD, of Abramson Cancer Center at the University of Pennsylvania, discusses the Commission on Cancer’s efforts to promote robust survivorship care and how its new recommendations will affect clinical practice and patients.
